Regions Financial Corp’s Charles River Laboratories CRL Stock Holding History

Regions Financial Corp’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-9	Closed	-$1K	–	1000
2019 Q1	$1K	Hold	9	–	–	﹤0.01%	1835
2018 Q4	$1K	Hold	9	–	–	﹤0.01%	1809
2018 Q3	$1K	Hold	9	–	–	﹤0.01%	1896
2018 Q2	$1K	Buy	9 +8	+800%	+$865	﹤0.01%	1986
2018 Q1	$0	Sell	1 -255	-100%	-$27.5K	﹤0.01%	1991
2017 Q4	$28K	Buy	+256	New	+$27.9K	﹤0.01%	1397

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Regions Financial Corp's CRL Position: Q2 2019 in Review

Regions Financial Corp sold out of Charles River Laboratories (CRL) in Q2 2019, closing a stake of 9 shares — an estimated $1K sold.

Regions Financial Corp first reported a position in CRL in Q4 2017 and held it in 6 quarters. The position peaked at $28K in Q4 2017. 405 funds tracked by Wall St. Rank hold CRL as of Q2 2019.

Regions Financial Corp reported no remaining Charles River Laboratories position as of Q2 2019 after selling out during the quarter.
Regions Financial Corp sold 9 Charles River Laboratories shares in Q2 2019, an estimated $1K.
Regions Financial Corp first reported a position in Charles River Laboratories in Q4 2017 and held it in 6 quarters.
Regions Financial Corp's Charles River Laboratories position peaked at $28K in Q4 2017.
405 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2019.

Based on Regions Financial Corp's 13F filing for Q2 2019, filed 19 Jul 2019.